Browse > Article
http://dx.doi.org/10.7314/APJCP.2015.16.4.1397

Overexpression of Tbx3 Predicts Poor Prognosis of Patients with Resectable Pancreatic Carcinoma  

Wang, Hong-Cheng (Department of General Surgery, Sixth People's Hospital Affiliated Shanghai Jiao Tong University)
Meng, Qing-Cai (Department of General Surgery, Sixth People's Hospital Affiliated Shanghai Jiao Tong University)
Shan, Ze-Zhi (Department of General Surgery, Sixth People's Hospital Affiliated Shanghai Jiao Tong University)
Yuan, Zhou (Department of General Surgery, Sixth People's Hospital Affiliated Shanghai Jiao Tong University)
Huang, Xin-Yu (Department of General Surgery, Sixth People's Hospital Affiliated Shanghai Jiao Tong University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.16, no.4, 2015 , pp. 1397-1401 More about this Journal
Abstract
Background: To determine the expressions of Tbx3, a member of subgroup belonging to T-box family, and its prognostic value in pancreatic carcinoma. Materials and Methods: We determined the expression levels of Tbx3 on both mRNA and protein levels in 30 pairs of fresh tumor tissues and paratumor tissues by quantitative real-time polymerase chain reaction (qRT-PCR) and Western blotting, respectively. In addition, protein level of Tbx3 were identified using immunochemistry in 80 pairs of paraffin-embedded specimen. The correlations between Tbx3 expression and various clinicopathological parameters as well as overall survival were evaluated. Results: Tbx3 mRNA and protein levels in tumor tissues were significantly higher than in the paratumor tissues by qRT-PCR ($0.05{\pm}0.007$ vs. $0.087{\pm}0.001$, p<0.001) and western blotting ($1.134{\pm}0.043$ vs. $0.287{\pm}0.017$, p<0.001). The statistical analysis based on immunohistochemical evaluation suggested that Tbx3 aberrant expression was significantly associated with several conventional clinicopathological variables, such as gender, age, tumor position, preoperative CA19-9 level, pathological T staging and N staging. Univariate and multivariate analyses revealed that Tbx3 expression was an independent prognostic factor for overall survival (<0.001). Conclusions: Our results suggest that overexpression of Tbx3 is associated with poor prognosis of pancreatic cancer patients. However, additional clinical trials are needed to accurately validate this observation.
Keywords
Tbx3; pancreatic carcinoma; prognosis;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Ansari D, Rosendahl A, Elebro J, et al (2011). Systematic review of immunohistochemical biomarkers to identify prognostic subgroups of patients with pancreatic cancer. Br J Surg, 98, 1041-55.   DOI
2 Ballim RD, Mendelsohn C, Papaioannou VE, et al (2012). The ulnar-mammary syndrome gene, Tbx3, is a direct target of the retinoic acid signaling pathway, which regulates its expression during mouse limb development. Mol Biol Cell, 23, 2362-72.   DOI
3 Begum S, Papaioannou VE (2011). Dynamic expression of Tbx2 and Tbx3 in developing mouse pancreas. Gene Expr Patterns, 11, 476-83.   DOI
4 Carlson H, Ota S, Song Y, et al (2002). Tbx3 impinges on the p53 pathway to suppress apoptosis, facilitate cell transformation and block myogenic differentiation. Oncogene, 21, 3827-35.   DOI
5 Cavard C, Audebourg A, Letourneur F, et al (2009). Gene expression profiling provides insights into the pathways involved in solid pseudopapillary neoplasm of the pancreas. J Pathol, 218, 201-9.   DOI
6 Chapman DL, Garvey N, Hancock S, et al (1996). Expression of the T-box family genes, Tbx1-Tbx5, during early mouse development. Dev Dyn, 206, 379-90.   DOI
7 Du HF, Ou LP, Yang X, et al (2014). A new PKCalpha/beta/TBX3/E-cadherin pathway is involved in PLCepsilonregulated invasion and migration in human bladder cancer cells. Cell Signal, 26, 580-93.   DOI
8 Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al (2013). Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer, 49, 1374-403.   DOI   ScienceOn
9 Fillmore CM, Gupta PB, Rudnick JA, et al (2010). Estrogen expands breast cancer stem-like cells through paracrine FGF/Tbx3 signaling. Proc Natl Acad Sci U S A, 107, 21737-42.   DOI
10 Hansel DE, Rahman A, House M, et al (2004). Met protooncogene and insulin-like growth factor binding protein 3 overexpression correlates with metastatic ability in welldifferentiated pancreatic endocrine neoplasms. Clin Cancer Res, 10, 6152-8.   DOI
11 Hidalgo M (2010). Pancreatic cancer. N Engl J Med, 362, 1605-17.   DOI
12 Li D, Xie K, Wolff R, et al (2004). Pancreatic cancer. Lancet, 363, 1049-57.   DOI
13 Howard B, Ashworth A (2006). Signalling pathways implicated in early mammary gland morphogenesis and breast cancer. PLoS Genet, 2, 112.   DOI   ScienceOn
14 Ito A, Asamoto M, Hokaiwado N, et al (2005). Tbx3 expression is related to apoptosis and cell proliferation in rat bladder both hyperplastic epithelial cells and carcinoma cells. Cancer Lett, 219, 105-12.   DOI
15 Kim J, Chu J, Shen X, et al (2008). An extended transcriptional network for pluripotency of embryonic stem cells. Cell, 132, 1049-61.   DOI
16 Li J, Weinberg MS, Zerbini L, et al (2013). The oncogenic TBX3 is a downstream target and mediator of the TGF-beta1 signaling pathway. Mol Biol Cell, 24, 3569-76.   DOI
17 Lomnytska M, Dubrovska A, Hellman U, et al (2006). Increased expression of cSHMT, Tbx3 and utrophin in plasma of ovarian and breast cancer patients. Int J Cancer, 118, 412-21.   DOI
18 Lyng H, Brovig RS, Svendsrud DH, et al (2006). Gene expressions and copy numbers associated with metastatic phenotypes of uterine cervical cancer. BMC Genomics, 7, 268.   DOI
19 Minguillon C, Logan M (2003). The comparative genomics of T-box genes. Brief Funct Genomic Proteomic, 2, 224-33.   DOI
20 Mowla S, Pinnock R, Leaner VD, et al (2011). PMA-induced up-regulation of TBX3 is mediated by AP-1 and contributes to breast cancer cell migration. Biochem J, 433, 145-53.   DOI
21 Muller CW, Herrmann BG (1997). Crystallographic structure of the T domain-DNA complex of the Brachyury transcription factor. Nature, 389, 884-8.   DOI
22 Rowley M, Grothey E, Couch FJ (2004). The role of Tbx2 and Tbx3 in mammary development and tumorigenesis. J Mammary Gland Biol Neoplasia, 9, 109-18.   DOI
23 Peres J, Davis E, Mowla S, et al (2010). The Highly Homologous T-Box Transcription Factors, TBX2 and TBX3, Have Distinct Roles in the Oncogenic Process. Genes Cancer, 1, 272-82.   DOI
24 Renard CA, Labalette C, Armengol C, et al (2007). Tbx3 is a downstream target of the Wnt/beta-catenin pathway and a critical mediator of beta-catenin survival functions in liver cancer. Cancer Res, 67, 901-10.   DOI
25 Rodriguez M, Aladowicz E, Lanfrancone L, et al (2008). Tbx3 represses E-cadherin expression and enhances melanoma invasiveness. Cancer Res, 68, 7872-81.   DOI
26 Schmalhofer O, Brabletz S, Brabletz T (2009). E-cadherin, beta-catenin, and ZEB1 in malignant progression of cancer. Cancer Metastasis Rev, 28, 151-66.   DOI
27 Siegel R, Naishadham D, Jemal A (2013). Cancer statistics, 2013. CA Cancer J Clin, 63, 11-30.   DOI   ScienceOn
28 Washkowitz AJ, Gavrilov S, Begum S, et al (2012). Diverse functional networks of Tbx3 in development and disease. Wiley Interdiscip Rev Syst Biol Med, 4, 273-83.   DOI
29 Winter JM, Yeo CJ, Brody JR (2013). Diagnostic, prognostic, and predictive biomarkers in pancreatic cancer. J Surg Oncol, 107, 15-22.   DOI
30 Yan W, Cao QJ, Arenas RB, et al (2010). GATA3 inhibits breast cancer metastasis through the reversal of epithelialmesenchymal transition. J Biol Chem, 285, 14042-51.   DOI
31 Zhang JF, He ML, Qi D, et al (2011). Aqueous extracts of Fructus Ligustri Lucidi enhance the sensitivity of human colorectal carcinoma DLD-1 cells to doxorubicin-induced apoptosis via Tbx3 suppression. Integr Cancer Ther, 10, 85-91.   DOI